Dexcom Sees FY24 Revenue $4.00B-$4.05B vs $4.33B Est.
Portfolio Pulse from Benzinga Newsdesk
Dexcom has announced its FY24 revenue guidance to be between $4.00 billion and $4.05 billion, which is below the estimated $4.33 billion.
July 25, 2024 | 8:28 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Dexcom's FY24 revenue guidance of $4.00 billion to $4.05 billion is below the market estimate of $4.33 billion, which may lead to a negative short-term impact on the stock price.
The revenue guidance provided by Dexcom is significantly below market expectations. This discrepancy is likely to cause concern among investors, leading to a potential short-term decline in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100